Summary:We noted a significant increase of interleukin-8 (IL-8), LBP and CRP mirroring the pattern of mucosal barrier injury as measured by gut integrity (lactulose/rhamnose ratio), daily mucositis score (DMS) and serum citrulline concentrations of 32 haematopoietic stem cell transplant (HSCT) recipients following intensive myeloablative therapy. Concentrations of IL-8, LBP and CRP were already significantly elevated before the onset of fever or bacteraemia due to oral viridans streptococci (OVS) in the first week after transplant during profound neutropenia. These markers reached their peak when citrulline concentrations reached their nadir, the highest scores of DMS were attained and when there was significantly decreased gut integrity. This suggests that the degree of mucosal barrier injury rather than bacteraemia due to OVS determines the intensity of the inflammatory response. 1 It begins immediately after starting anticancer therapy with the activation of the nuclear transcription factor NF-kB resulting in the production and release of proinflammatory cytokines by various cells including lymphocytes, macrophages, endothelial cells and gut epithelial cells.2,3 Gut epithelial cells produce not only proinflammatory cytokines like TNF-a, interleukin (IL)-1a and IL-6, but also the chemokines, monocyte chemoattractant protein-1 (MCP-1) and IL-8, antimicrobial peptides (defensins, cathelicidins, lactoferrin) and the acute phase protein, LPS-binding protein (LBP).3-5 The release of proinflammatory cytokines and the blocking of clonogenic epithelial stem cell renewal results in apoptosis and necrosis, which manifests itself as epithelial atrophy and ulcerative lesions.6 The latter are a potential portal of entry for oral viridans (alpha-haemolytic) streptococci (OVS), which are universal commensals of the oral cavity placing haematopoietic stem cell transplant (HSCT) recipients at risk of developing bacteraemia due to these bacteria. 7 Our standard myeloablative regimen of idarubicin, cyclophosphamide and TBI to prepare patients for a T-cell depleted HSCT 8 is known to induce prolonged and severe MBI of the oral cavity and digestive tract.9 This is invariably accompanied by fever and bacteraemia due to frequent occurrence of viridans streptococci 10 as well as the continued release of C-reactive protein (CRP) (unpublished observation). We prospectively routinely determined CRP concentrations throughout admission of 32 HSCT recipients participating in a prospective randomised placebo-controlled study of glutamine-dipeptide-enriched parenteral nutrition and collected serum and plasma samples for measuring IL-8 and LBP later. We were particularly interested in investigating production of IL-8 and LBP together with CRP to determine the proinflammatory response of the gut during the process of MBI as defined by oral mucositis, sugar permeability tests (SPT) and serum citrulline concentrations.
11
Patients and methods
PatientsA total of 32 patients (12 F; 20 M) with a mean age of 48 years (range 25-65) had given their in...